Revenues will most likely be poor as imho they always are. Guess what won't be poor? Management compensation...... as always. I would like to know who the dolts are that keep buying into the seemingly endless Private Placements and underwhelming pumps. 

What's the word on Cavaltinib? Better get that pump PR ready. The covid numbers seem to be increasing slightly. Anyone still invested here will get what they deserve. Good or BAD